Movie & TV
Past 24 hours
Past 7 days
Past 30 days
Complete Revascularization Benefits May Be Due to Stenting Vulnerable Plaques
PHILADELPHIA, PA—In patients with STEMI and multivessel disease, the reduction in CV death or new MI achieved in the COMPLETE ...
Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare
LONDON, England—Follow-up data from the PORTICO I study testing the self-expanding Portico transcatheter heart valve (Abbott) ...
Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE
PHILADELPHIA, PA—The first phase III study of a novel drug that inhibits the bromodomain extra-terminal (BET) protein pathway ...
Signal of Impaired Sapien XT Durability in Midterm Follow-up
LONDON, England—A new analysis of intermediate-risk patients treated with Sapien XT and Sapien 3 (Edwards Lifesciences) in ...
Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS
PHILADELPHIA, PA—Physicians shouldn’t be too hasty about dropping aspirin in all A-fib patients after PCI, as it appears ...
Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit
PHILADELPHIA, PA—Immediate angiography among comatose cardiac arrest patients who lack signs of STEMI and are successfully ...
Inclisiran in FH: Safe, Cuts LDL in This Challenging Group
PHILADELPHIA, PA—New inclisiran data presented here show safety and efficacy in patients with familial hypercholesterolemia ...
Early Data Favorable for New RNAi Therapies to Reduce Triglycerides
PHILADELPHIA, PA—Therapies using RNA interference (RNAi) to target genes that encode proteins involved in lipid and ...
Grief and CVD: Simple Regimen May Lower Risk
A low-dose beta-blocker and aspirin regimen may buffer some of the physiologic stress of losing a loved one that puts newly ...
Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients
LONDON, England – Fewer than one in seven patients with secondary mitral regurgitation (MR) would be eligible for ...
EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl
PHILADELPHIA, PA—Preliminary data suggest that icosapent ethyl (Vascepa; Amarin) slows the progression of atherosclerosis in ...
Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial
PHILADELPHIA, PA—Prescribing statins to achieve a more aggressive LDL treatment target in patients who have had a TIA or ...